130 related articles for article (PubMed ID: 38030277)
1. Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings.
Takeda K; Suzuki J; Sasaki Y; Watanabe A; Kamei K
Med Mycol J; 2023; 64(4):95-98. PubMed ID: 38030277
[TBL] [Abstract][Full Text] [Related]
2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
[TBL] [Abstract][Full Text] [Related]
4. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
[TBL] [Abstract][Full Text] [Related]
5. Cryptic species and azole resistance in the Aspergillus niger complex.
Howard SJ; Harrison E; Bowyer P; Varga J; Denning DW
Antimicrob Agents Chemother; 2011 Oct; 55(10):4802-9. PubMed ID: 21768508
[TBL] [Abstract][Full Text] [Related]
6. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
7. CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi.
Van Rhijn N; Bromley M; Richardson M; Bowyer P
mBio; 2021 Oct; 12(5):e0194521. PubMed ID: 34607450
[TBL] [Abstract][Full Text] [Related]
8. New Insights into the Cyp51 Contribution to Azole Resistance in
Pérez-Cantero A; López-Fernández L; Guarro J; Capilla J
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061160
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis.
Wang Y; Zhang L; Zhou L; Zhang M; Xu Y
Front Public Health; 2022; 10():835092. PubMed ID: 35493371
[TBL] [Abstract][Full Text] [Related]
10. The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study.
Takeda K; Suzuki J; Watanabe A; Sekiguchi R; Sano T; Watanabe M; Narumoto O; Kawashima M; Fukami T; Sasaki Y; Tamura A; Nagai H; Matsui H; Kamei K
Mycoses; 2022 Feb; 65(2):164-170. PubMed ID: 34783396
[TBL] [Abstract][Full Text] [Related]
11. Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
Siopi M; Rivero-Menendez O; Gkotsis G; Panara A; Thomaidis NS; Alastruey-Izquierdo A; Pournaras S; Meletiadis J
J Antimicrob Chemother; 2020 Nov; 75(11):3181-3188. PubMed ID: 32814940
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.
Wei X; Zhang Y; Lu L
J Microbiol; 2015 Feb; 53(2):91-9. PubMed ID: 25626363
[TBL] [Abstract][Full Text] [Related]
16. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
[TBL] [Abstract][Full Text] [Related]
17. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
19. An expanded agar-based screening method for azole-resistant Aspergillus fumigatus.
Lucio J; Gonzalez-Jimenez I; Garcia-Rubio R; Cuetara MS; Mellado E
Mycoses; 2022 Feb; 65(2):178-185. PubMed ID: 34806786
[TBL] [Abstract][Full Text] [Related]
20. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
